Ed Field is president and CEO of Aldagen, a clinical stage, regenerative medicine company in Durham, NC

One of the most promising forms of emerging therapy is the use of a person's own or a donor's cells to treat a variety of diseases. This approach, often called cell therapy and more recently regenerative medicine, attracts a great deal of attention because the therapeutic use of stem cells falls into this category. Many US states and other countries developed strategic plans to attract the top researchers, clinicians, and companies competing in this space. North Carolina does not have a specific plan to support this effort, despite already having many of the key elements that other regions covet. This article outlines action items that might keep North Carolina in...

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?